Bacillus subtilis(DreamTec)

N/A

Report date: 2024/07/23 15:58:21

Base Information

Drug NameBacillus subtilis(DreamTec)
Drug Alias NameCOVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores(DreamTec)
ClassificationBiologics > Live BiotherapeuticNatural product/Extract > Microbial extractVaccines > Application > Prophylactic vaccine
Mechanisms of ActionBacteria replacementsImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMacau
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesDreamTec Research LtdDreamTec Cytokine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDreamTec Research Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A